Temporal Expression Pattern Of The Insulin-like Growth Factor Ii And Fibroblast Growth Factor Transcripts In Vian Embryogenesis by Gabriel J.E. et al.
 Braz. arch. biol. technol. v.51 n.5: pp.949-955, Sept/Oct 2008 
949 
Vol. 51, n. 5 : pp.949-955, September-October 2008 
ISSN 1516-8913    Printed in Brazil 
 BRAZILIAN ARCHIVES OF  
BIOLOGY AND TECHNOLOGY 
  
A N  I N T E R N A T I O N A L  J O U R N A L  
 
 
 
Temporal Expression Pattern of the Insulin-like Growth 
Factor II and Fibroblast Growth Factor Transcripts in 
Avian Embryogenesis 
 
Jane Eyre Gabriel1*, Lúcia Elvira Alvares2 and Luiz Lehmann Coutinho3 
1Centro de Ciências Exatas e Sociais Aplicada; Universidade Estadual da Paraíba; 58700-08; Patos - PB - Brasil. 
2Instituto de Biologia; Universidade Estadual de Campinas; 13083-970; Campinas - SP – Brasil. 3Departamento de 
Produção Animal; Escola Superior de Agricultura Luiz de Queiroz; Universidade de São Paulo; 13418-900; 
Piracicaba - SP - Brasil 
 
 
ABSTRACT 
 
In this study, the abundance of IGF–II and bFGF transcripts was estimated in the chicken embryos using the 
competitive RT-PCR analysis. Significant enhancements in the abundance of IGF-II mRNA were observed at stages 
HH1 and 5, and a new accumulation in these levels was observed at stage HH18 in comparison to the basal levels. 
The abundance of bFGF mRNA increased significantly at stages HH18 and 20, followed by an upregulation in the 
expression of these transcripts at stage HH26. These findings provided important information about the temporal 
expression pattern of IGF-II and bFGF transcripts in the whole chicken embryos during in ovo development. 
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INTRODUCTION 
 
The animal embryogenesis is remarkably equipped 
for precise mechanisms of the cellular 
proliferation and differentiation until the formation 
of functional tissue. Insulin-like growth factors 
(IGFs) and fibroblast growth factors (FGFs) are 
mitogenic agents that play fundamental regulatory 
roles during the embryo development, since these 
peptides regulate cell fate by activating the 
multiple transduction pathways.  
Somatomedins (IGF-I and –II) comprise a family 
of the polypeptides with the growth-promoting 
effects in a wide variety of the cultured cells 
(Florini et al., 1991; Florini et al., 1996; Pirskanen 
et al., 2000). It has been shown that these factors 
stimulate the proliferation, differentiation and 
protein accretion of the cells derived from the 
avian embryos (Szebenyi and Fallon, 1999). In 
vitro analysis shows that IGFs promote the 
terminal cellular differentiation for an expression- 
and secretion-dependent autocrine mechanism. 
Contrary to that observed in the mammals, IGF-I 
and -II exert similar effects in the chicken embryos 
due to the absence of type-II IGF receptors. The 
IGF-II gene is essential for the normal embryonic 
and postnatal growth and plays an important role 
in the functioning of a healthy immune system, 
lymphopoiesis, myogenesis and bone growth 
among other physiological functions (Denley et 
al., 2005). 
The members of the FGF family are important 
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molecules involved at the early steps of the 
morphogenetic processes and include the major 
regulators of the embryonic development (Sanchez 
et al., 2001). They influence the formation of the 
primary body axis, neural axis, limbs and other 
embryonic structures. The activities of the FGFs 
depend on their coordination of the fundamental 
cellular functions, such as survival, replication, 
differentiation, adhesion and motility, through the 
effects on gene expression and on the cytoskeleton 
(Szebenyi and Fallon, 1999). The basic fibroblast 
growth factor, also known as bFGF or FGF2, is a 
particularly potent mitogen and promotes the cell 
survival by inhibiting the apoptosis. At the tissue 
level, it is involved in wound repair and induces 
the angiogenesis (Muramatsu et al., 2002). 
Additionally, bFGF is a significant target in the 
cancer research because it is over-expressed in 
some cancers and may enhance a tumor's 
metastatic potential (Castelli et al., 2004). 
Although the effects of the growth factors on the 
cultured cells have been extensively reported 
(Florini et al., 1996), their expression pattern and 
relationship with the development processes of the 
embryogenesis has not been well developed. Thus, 
the aim of this study was to estimate the 
abundance of the IGF-II and bFGF mRNAs in 
chicken embryos throughout different 
developmental stages in order to verify the 
temporal expression pattern of these growth 
regulatory genes during in ovo development. 
 
 
MATERIAL AND METHODS 
 
Embryo collection and total RNA extraction 
Fertilized chicken eggs from Cobb500 line were 
incubated at 37±0.5°C and 60% relative humidity. 
Fifteen embryos were surgically collected and 
staged according to Hamburger and Hamilton 
(1951). The analyzed developmental stages were 
HH1 (blastoderm stage, unincubated embryo), 5, 
8, 10, 12, 15, 18, 20, 21, 23, 24 and 26 (fifth day 
of incubation). After the removal of the 
membranes, the whole embryos were immediately 
dissolved in TRIZOL reagent (Invitrogen). Total 
RNA extraction was performed as described by 
Chomczynski and Sacchi (1987). These samples 
were resuspended in 20-100 µl of sterile nuclease-
free water for the determination of their 
concentrations. The integrity of the ribosomal 
RNA bands was observed on agarose gels under 
the denaturant conditions (Sambrook et al., 1989). 
 
RT-PCR analysis  
Single-strand cDNA synthesis was carried out 
from 1 µg of the total RNA by the reverse 
transcription (RT) reaction. After the denaturation 
at 70°C for 10 min, RNA samples were incubated 
in 1X PCR buffer  (10 mM Tris-HCl, pH 9.5, 50 
mM KCl, 0.1% Triton X-100), 2.5 mM MgCl2, 1 
mM dNTPs mix, 500 ng oligo(dT) primer, and 200 
U SuperScriptII enzyme (Invitrogen) in a final 
volume of 20 µl. This reaction was maintained at 
42°C for 50 min and subsequently incubated with 
1 U of RNase H for 20 min at 37°C for the RNA 
template digestion. 
The amplification reactions were conducted using 
the sense and antisense primers as shown in Table 
1. All the primers were designed to flank an intron 
to avoid the same-size amplification of the 
contaminating genomic DNA. The PCRs were 
performed with 10% of total RT reaction volume, 
0.5 µM specific primers (Table 1), 1X PCR buffer 
(10 mM Tris-HCl, 1.5-2.5 mM MgCl2, 50 mM 
KCl), and 1 U Taq DNA polymerase (Invitrogen). 
These reactions were denatured at 94°C for 30 
seconds, followed by annealing for 40 seconds and 
extension corresponding to 72°C for 40 seconds. 
The annealing temperatures for IGF-II and bFGF 
genes were 57 and 58°C, respectively and the 
cycle number ranged from 20 to 40 in function of 
the mRNA abundance. The identity of the 
amplified products was confirmed by digestion 
with the restriction enzymes (Table 1). 
 
Construction of native and competitor 
fragments 
The mRNA expression levels of IGF-II, bFGF and 
β-actin genes were estimated using a modified 
experimental procedure of the quantitative-
competitive RT-PCR initially described by Tsai 
and Wiltbank (1996) and reported in detail by 
Gabriel et al. (2003). Two cDNA fragments for 
each gene were generated in order to construct the 
standard curves. To synthesize the native cDNA 
fragments of the genes of the interest, the RT 
reaction was performed exactly as described 
above, since these fragments were identical in size 
and nucleotide sequence to the cDNA obtained by 
the RT-PCR of the embryos. The competitor 
cDNA fragments were generated using the 
identical primer binding sites with the native 
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template and these fragments were produced by 
mutational PCR with the antisense deletion 
primers (Table 1). The deletion primers were 
composed of 19 bases complementary to an 
internal region of the target template in addition to 
20 bases identical to the antisense primer. After 
the amplification, the region downstream from the 
deletion primer site was eliminated in the 
competitor, resulting in a smaller fragment. 
However, the deletion primer contained the 
complete sequence of the antisense primer site and 
this stretch was rescued in the copied fragment. 
Consequently, the same primer pairs could be 
employed to amplify both the native and 
competitor cDNAs. Since the region to which 
primers bind was common, the competitor and 
native DNA fragments competed equally for the 
limiting reaction components (nucleotides, primers 
and enzyme). 
The native and competitor fragments were 
amplified from 10% of RT reactions, eluted from 
the agarose gel using the Sephaglass Elution kit 
(Amersham Pharmacia Biotech) and cloned in the 
expression vectors using the SureClone Ligation 
kit (Amersham Pharmacia Biotech). To confirm 
the identity and the deletion of the desired 
sequences, these clones were sequenced with the 
BigDye Terminator kit (Applied Biosystems) 
using an ABI PRISM 377 automated DNA 
sequencer. 
 
Table 1 - Primer sequences, restriction sites and fragments. 
 
Gene 
Amplified 
products (bp) 
 
Primer sequences 
Restriction sites 
and fragments 
IGF-II a 330 (S) 5’TGCCAAGTCCGTCAAGTCAGAGCG3’ EcoRI 
  (AS) 5’CCGGCTGGTCACAGTTCATTCC3’ 230 + 100 
 290 (C) 5’TGCCAAGTCCGTCAAGTCAGAGCGTCAACAAGGAGAGCT3’ 
 
 
bFGF b 270 (S) 5’GATCCGCACATCAAACTGC3’ HinfI 
  (AS) 5’GATAGCTTTCTGTCCAGGTCC3’ 158 + 112 
 240 (C) 5’ GATAGCTTTCTGTCCAGGTCCCTTTTCAGTGCCACA3’ 
 
 
β-actin c 409 (S) 5’AATGAGAGGTTCAGGTGCCC3’ HindIII 
  (AS) 5’ATCACAGGGGTGTGGGTGTT3’ 280 + 129 
 319 (C) 
5’ATCACAGGGGTGTGGGTGTTGTGGACAGGGAGGCCAGGA3’ 
 
    
Underlined sequences correspond to same anchorage sites of sense or antisense primers. S, AS, C: sense, antisense and deletion 
primers, respectively. a. Darling et al. (1996). b. Borja et al. (1993). c. Kost et al. (1983). 
 
 
Construction of standard curves and 
determination of expression levels of interest 
genes 
The transcript abundance was estimated by the 
direct comparison with the standard curves 
obtained from increasing and known amounts of 
the native cDNA in the presence of the constant 
amount of the competitor cDNA (Gabriel et al., 
2003). Serial dilutions of the native cDNA 
fragment were performed in the water containing 
10 ng/µl of the plasmidial DNA (with no insert) as 
the carrier. The amount of the native cDNA added 
to each PCR varied from 25.6 X 10-n to 0.1 X 10-n 
while a fixed amount of 1 X 10-n of the competitor 
fragment was maintained, where n corresponded to 
co-amplification range in which each standard-
curve was constructed. 
The amount of the competitor fragment used for 
each gene was determined by the titration 
experiments, in which a different amount of the 
competitor cDNA was co-amplified with the 
experimental sample. The co-amplification range 
for IGF-II and bFGF genes was 10-5. The β-actin 
expression levels were determined in order to 
correct the variations in the total RNA 
quantification and in reverse transcription 
efficiency, and thus, normalize the mRNA 
abundance of genes of interest. 
A known amount of the competitor was directly 
added to the 1 X PCR master mixture to assure 
that an equal amount was present in all the 
samples analyzed. To monitor the possible DNA 
contaminations, negative controls were included in 
each batch of the PCR. Sense primers were 5’-
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labelled with the fluorescein and aliquots of the 
amplified products were submitted to the 
electrophoresis in an Automated Laser Fluorescent 
DNA Sequencer (A.L.F.TM, Pharmacia LKB 
Biotechnology). Following the electrophoresis, the 
peaks derived from the native and competitor 
templates were integrated with the Fragment 
Manager software (Pharmacia LKB 
Biotechnology). The logarithmic proportion of the 
native to competitor cDNA peak areas (log N/C) 
and the initial concentration logarithm of the 
native cDNA (log Ni) were employed for the 
standard curve construction. Finally, the 
mathematical equation obtained by the linear 
regression of the standard curves was used to 
determine variations in the mRNA abundance of 
genes of interest in the embryonic cDNA samples 
based on the ratio of the native to competitor 
products in individual PCRs. 
 
Statistical analysis 
The data obtained in the quantitative assays were 
statistically analyzed by the regression analysis 
using the GLM procedure of SAS (1999). The 
data corresponding to bFGF gene were submitted 
to the logarithmic transformation, whereas results 
concerning IGF-II gene were estimated by the 
square root transformation as proposed by Cook 
and Weisberg (1994). The statements of 
significance were based on P<0.05 unless 
otherwise noted. 
 
 
RESULTS AND DISCUSSION 
 
The abundance of IGF-II and bFGF transcripts 
was estimated in the chicken embryos at different 
developmental stages using competitive RT-PCR 
analysis (Fig 1). Three-fold accumulation in IGF-
II transcript levels was detected significantly at 
stages HH1 (blastoderm) and 5 (p<0.05) (Fig 1A).  
This could be explained by the fact that after the 
hatching, the blastoderm presented thousand of the 
cells in an active process of the cellular division 
that mobilized all the information needed by the 
functional developing chicken embryos 
(Hamburger and Hamilton, 1951). A second 
significant peak in these levels was detected in the 
chicken embryos at stage HH18 and 20 in 
comparison to the basal levels (p<0.05) (Fig 1A).  
Thus, the enhancements in the levels of IGF-II 
mRNA found in the chicken embryos at early 
developmental stages could indicate its 
fundamental participation as a potent mitogenic 
agent, regulating the important pathways of the 
cellular proliferation during the embryogenesis. 
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Figure 1 - Abundance of IGF-II (A) and bFGF (B) transcripts in chicken embryos at different 
developmental stages. Values are presented as arbitrary units. Significant difference 
compared to basal levels: *p<0.05, **p<0.01. 
 
 
The basal levels in the expression of the bFGF 
gene were detected from stages HH1 until 15 
(p>0.05) (Fig 1B). Significant three-fold 
enhancements in these levels were found at stages 
HH18 and 20 (p<0.05) compared to the basal 
levels (Fig 1B). Although Hannon et al. (1992) 
found that this factor was not expressed during the 
early mouse embryonic development, the findings 
presented in this study showed enhancements in 
the levels of bFGF mRNA from stage 18 and 20 in 
the whole chicken embryos (p<0.05) (Fig 1B).  
This accentuated expression could trigger the 
cellular differentiation events and the formation of 
the bud limb in the chicken embryos, as also 
observed in the chicken embryos at the same 
developmental stage by Cohn et al. (1995) and 
Ohuchi et al. (1997). 
A new significant six-fold peak in abundance of 
bFGF mRNA was observed for stage HH26 
compared to the basal levels (p<0.01) (Fig 1B). 
The upregulation of bFGF mRNA at stage HH26 
in the whole chicken embryos reinforced the 
findings described by Kocamis and Killefer 
(2003), which observed an accentuated expression 
of these transcripts in the skeletal muscle tissue 
isolated from the chicken embryos at the same 
developmental stage. The evidence presented in 
this study suggested that the bFGF gene exerted a 
crucial role in the modulation of the cellular 
differentiation events in the avian embryogenesis. 
Under these experimental conditions, the 
differences in the transcript abundance between 
the both growth factors were detected in the 
embryos at stages 1, 5, 18, 20 and 26 (p>0.01) (Fig 
1). Except at stage 26, the levels of IGF-II mRNA 
were higher than those observed in bFGF (Fig 1). 
The growth factors act as signaling molecules in a 
wide variety of biological events in the vertebrates 
and several studies have focused on the effects that 
these peptides have on the molecular basis 
involved in the deposition of the skeletal muscle 
tissue (Pownall and Emerson, 1992, Bass et al., 
1999). Considering that the FGF signaling 
pathways were intricately intertwined with IGFs 
(Szebenyi and Fallon, 1999), it could be 
speculated that these genes could interact 
synergistically in order to modulate distinct 
myogenic events during early avian 
embryogenesis. Further research is necessary to 
address the complex modulation network of the 
regulatory gene machinery that these growth 
factors exert in ovo development.  
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In conclusion, the findings described in this study 
provided important insights into the temporal 
expression pattern of IGF-II and bFGF genes 
during early avian embryogenesis. 
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RESUMO 
 
Fatores de crescimento coordenam múltiplas vias 
de sinalização durante o desenvolvimento 
embrionário. Neste estudo, a abundância de 
mRNA dos genes IGF-II e bFGF foi estimada em 
embriões de galinha por análises de RT-PCR 
competitiva. Aumentos na abundância de mRNA 
de IGF-II foram observados nos estádios HH1, 5. 
Os níveis de mRNA de bFGF exibiram aumentos a 
partir dos estádios HH18 e 20, seguido por uma 
acentuada redução a níveis basais no estádio HH24 
e por um segundo pico na expressão destes 
transcritos no estádio HH26. Tais descobertas 
proporcionam importantes informações sobre o 
padrão de expressão destes fatores de crescimento 
durante a embriogênese de aves. 
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